These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26854485)

  • 1. Expression of the MOZ-TIF2 oncoprotein in mice represses senescence.
    Largeot A; Perez-Campo FM; Marinopoulou E; Lie-a-Ling M; Kouskoff V; Lacaud G
    Exp Hematol; 2016 Apr; 44(4):231-7.e4. PubMed ID: 26854485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MOZ-mediated repression of p16(INK) (4) (a) is critical for the self-renewal of neural and hematopoietic stem cells.
    Perez-Campo FM; Costa G; Lie-A-Ling M; Stifani S; Kouskoff V; Lacaud G
    Stem Cells; 2014 Jun; 32(6):1591-601. PubMed ID: 24307508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MOZ-TIF2 repression of nuclear receptor-mediated transcription requires multiple domains in MOZ and in the CID domain of TIF2.
    Yin H; Glass J; Blanchard KL
    Mol Cancer; 2007 Aug; 6():51. PubMed ID: 17697320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A MOZ-TIF2 leukemia mouse model displays KAT6-dependent H3K23 propionylation and overexpression of a set of active developmental genes.
    Smolko AE; Sullivan DW; Olsen SN; Kang H; Whedon SD; Baell JB; Cole PA; Armstrong SA; Kuroda MI
    Proc Natl Acad Sci U S A; 2024 Jun; 121(26):e2405905121. PubMed ID: 38889153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.
    Shima H; Yamagata K; Aikawa Y; Shino M; Koseki H; Shimada H; Kitabayashi I
    Int J Hematol; 2014 Jan; 99(1):21-31. PubMed ID: 24258712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MOZ (MYST3, KAT6A) inhibits senescence via the INK4A-ARF pathway.
    Sheikh BN; Phipson B; El-Saafin F; Vanyai HK; Downer NL; Bird MJ; Kueh AJ; May RE; Smyth GK; Voss AK; Thomas T
    Oncogene; 2015 Nov; 34(47):5807-20. PubMed ID: 25772242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MOZ fusion proteins in acute myeloid leukaemia.
    Troke PJ; Kindle KB; Collins HM; Heery DM
    Biochem Soc Symp; 2006; (73):23-39. PubMed ID: 16626284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MOZ/TIF2-induced acute myeloid leukaemia in transgenic fish.
    Zhuravleva J; Paggetti J; Martin L; Hammann A; Solary E; Bastie JN; Delva L
    Br J Haematol; 2008 Nov; 143(3):378-82. PubMed ID: 18729850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2.
    Liang J; Prouty L; Williams BJ; Dayton MA; Blanchard KL
    Blood; 1998 Sep; 92(6):2118-22. PubMed ID: 9731070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP.
    Deguchi K; Ayton PM; Carapeti M; Kutok JL; Snyder CS; Williams IR; Cross NC; Glass CK; Cleary ML; Gilliland DG
    Cancer Cell; 2003 Mar; 3(3):259-71. PubMed ID: 12676584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT5 is crucial to maintain leukemic stem cells in acute myelogenous leukemias induced by MOZ-TIF2.
    Tam WF; Hähnel PS; Schüler A; Lee BH; Okabe R; Zhu N; Pante SV; Raffel G; Mercher T; Wernig G; Bockamp E; Sasca D; Kreft A; Robinson GW; Hennighausen L; Gilliland DG; Kindler T
    Cancer Res; 2013 Jan; 73(1):373-84. PubMed ID: 23149921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ring1A and Ring1B inhibit expression of Glis2 to maintain murine
    Shima H; Takamatsu-Ichihara E; Shino M; Yamagata K; Katsumoto T; Aikawa Y; Fujita S; Koseki H; Kitabayashi I
    Blood; 2018 Apr; 131(16):1833-1845. PubMed ID: 29371181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of the histone acetyltransferase monocytic leukemia zinc finger protein in normal and malignant hematopoiesis.
    Katsumoto T; Yoshida N; Kitabayashi I
    Cancer Sci; 2008 Aug; 99(8):1523-7. PubMed ID: 18754862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function.
    Kindle KB; Troke PJ; Collins HM; Matsuda S; Bossi D; Bellodi C; Kalkhoven E; Salomoni P; Pelicci PG; Minucci S; Heery DM
    Mol Cell Biol; 2005 Feb; 25(3):988-1002. PubMed ID: 15657427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MOZ is critical for the development of MOZ/MLL fusion-induced leukemia through regulation of Hoxa9/Meis1 expression.
    Katsumoto T; Ogawara Y; Yamagata K; Aikawa Y; Goitsuka R; Nakamura T; Kitabayashi I
    Blood Adv; 2022 Oct; 6(19):5527-5537. PubMed ID: 35947126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MOZ increases p53 acetylation and premature senescence through its complex formation with PML.
    Rokudai S; Laptenko O; Arnal SM; Taya Y; Kitabayashi I; Prives C
    Proc Natl Acad Sci U S A; 2013 Mar; 110(10):3895-900. PubMed ID: 23431171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2.
    Aikawa Y; Katsumoto T; Zhang P; Shima H; Shino M; Terui K; Ito E; Ohno H; Stanley ER; Singh H; Tenen DG; Kitabayashi I
    Nat Med; 2010 May; 16(5):580-5, 1p following 585. PubMed ID: 20418886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histone acetyl transferase activity of monocytic leukemia zinc finger is critical for the proliferation of hematopoietic precursors.
    Perez-Campo FM; Borrow J; Kouskoff V; Lacaud G
    Blood; 2009 May; 113(20):4866-74. PubMed ID: 19264921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MOZ-TIF2 alters cofactor recruitment and histone modification at the RARbeta2 promoter: differential effects of MOZ fusion proteins on CBP- and MOZ-dependent activators.
    Collins HM; Kindle KB; Matsuda S; Ryan C; Troke PJF; Kalkhoven E; Heery DM
    J Biol Chem; 2006 Jun; 281(25):17124-17133. PubMed ID: 16613851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The monocytic leukemia zinc finger protein MOZ is a histone acetyltransferase.
    Champagne N; Pelletier N; Yang XJ
    Oncogene; 2001 Jan; 20(3):404-9. PubMed ID: 11313971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.